Retraction: DNA damage induces NF-B-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion (Journal of Biological Chemistry (2017) 287 (21783–21795) DOI: 10.1074/jbc.M112.355495);DNA damage induces NF-κB-dependent MicroRNA-21 up-regulation and promotes breast cancer cell invasion

Journal of Biological Chemistry

Volumn 287, Issue 26, 2012, Pages 21783-21795

  Niu, Jixiao ^a   Shi, Yuling ^a   Tan, Guangyun ^a,b   Yang, Chuan He ^a   Fan, Meiyun ^a   Pfeffer, Lawrence M ^a   Wu, Zhao Hui ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CHEMICAL ACTIVATION; CHEMOTHERAPY; DNA; PATHOLOGY; RNA;

BREAST CANCER CELLS; CANCER METASTASIS; CHEMOTHERAPEUTIC DRUGS; CHROMATIN STRUCTURE; HUMAN MALIGNANCIES; INDUCED APOPTOSIS; METASTATIC POTENTIAL; SIGNAL TRANSDUCERS;

DISEASES;

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; DNA; DOXORUBICIN; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MEMBRANE RECEPTOR; MICRORNA 21; MITOGEN AND STRESS ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGRAMMED DEATH 4 RECEPTOR; PROTEIN SERINE THREONINE KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CHROMATIN STRUCTURE; DNA DAMAGE; ENZYME ACTIVATION; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TRANSPORT; RNA TRANSCRIPTION; TRANSACTIVATION; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION;

EID: 84862689246     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.W119.011598     Document Type: Erratum

References (59)

1. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300
2. Gonzalez-Angulo, A. M., Morales-Vasquez, F., and Hortobagyi, G. N. (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv. Exp. Med. Biol. 608, 1-22
3. Polyak, K., and Weinberg, R. A. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273
4. Ailles, L. E., and Weissman, I. L. (2007) Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 18, 460-466
5. Ben-Neriah, Y., and Karin, M. (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715-723
6. Baldwin, A. S. (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107, 241-246
7. Nakanishi, C., and Toi, M. (2005) Nuclear factor-κB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 5, 297-309
8. Wu, Z. H., Shi, Y., Tibbetts, R. S., and Miyamoto, S. (2006) Molecular linkage between the kinase ATM and NF-κB signaling in response to genotoxic stimuli. Science 311, 1141-1146
9. Wu, Z. H., Wong, E. T., Shi, Y., Niu, J., Chen, Z., Miyamoto, S., and Tergaonkar, V. (2010) ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol. Cell 40, 75-86
10. Niu, J., Shi, Y., Iwai, K., and Wu, Z. H. (2011) LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J. 30, 3741-3753
11. Biton, S., and Ashkenazi, A. (2011) NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feed-forward signaling. Cell 145, 92-103
12. Rodier, F., Coppé, J. P., Patil, C. K., Hoeijmakers, W. A., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., and Campisi, J. (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973-979
13. Coppé J. P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P. Y., and Campisi, J. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. Plos Biol. 6, 2853-2868
14. Fumagalli, M., and d'Adda di Fagagna, F. (2009) SASPense and DDRama in cancer and aging. Nat. Cell Biol. 11, 921-923
15. Taganov, K. D., Boldin, M. P., Chang, K. J., and Baltimore, D. (2006) NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103, 12481-12486
16. Yang, C. H., Yue, J., Fan, M., and Pfeffer, L. M. (2010) IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res. 70, 8108-8116
17. Zhou, R., Hu, G., Liu, J., Gong, A. Y., Drescher, K. M., and Chen, X. M. (2009) NF-κB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog. 5, e1000681
18. Polytarchou, C., Iliopoulos, D., Hatziapostolou, M., Kottakis, F., Maroulakou, I., Struhl, K., and Tsichlis, P. N. (2011) Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation. Cancer Res. 71, 4720-4731
19. Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., and O'Neill, L. A. (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11, 141-147
20. Ruan, Q., Wang, T., Kameswaran, V., Wei, Q., Johnson, D. S., Matschinsky, F., Shi, W., and Chen, Y. H. (2011) The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc. Natl. Acad. Sci. U.S.A. 108, 12030-12035
21. Bartel, D. P. (2004) MicroRNAs. Genomics, biogenesis, mechanism, and function. Cell 116, 281-297
22. Farazi, T. A., Spitzer, J. I., Morozov, P., and Tuschl, T. (2011) miRNAs in human cancer. J. Pathol. 223, 102-115
23. Garzon, R., Marcucci, G., and Croce, C. M. (2010) Targeting microRNAs in cancer. Rationale, strategies, and challenges. Nat. Rev. Drug Discov. 9, 775-789
24. Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., and Olson, E. N. (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18, 282-293
25. Medina, P. P., Nolde, M., and Slack, F. J. (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90
26. Farazi, T. A., Horlings, H. M., Ten Hoeve, J. J., Mihailovic, A., Halfwerk, H., Morozov, P., Brown, M., Hafner, M., Reyal, F., van Kouwenhove, M., Kreike, B., Sie, D., Hovestadt, V., Wessels, L. F., van de Vijver, M. J., and Tuschl, T. (2011) MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 71, 4443-4453
27. Yan, L. X., Huang, X. F., Shao, Q., Huang, M. Y., Deng, L., Wu, Q. L., Zeng, Y. X., and Shao, J. Y. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis, and patient poor prognosis. RNA 14, 2348-2360
28. Volinia, S., Galasso, M., Sana, M. E., Wise, T. F., Palatini, J., Huebner, K., and Croce, C. M. (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc. Natl. Acad. Sci. U.S.A. 109, 3024-3029
29. Ebert, M. S., Neilson, J. R., and Sharp, P. A. (2007) MicroRNA sponges. Competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721-726
30. Wu, Z. H., and Miyamoto, S. (2008) Induction of a pro-apoptotic ATM-NF-κB pathway and its repression by ATR in response to replication stress. EMBO J. 27, 1963-1973
31. Wu, Z. H., and Miyamoto, S. (2007) Many faces of NF-κB signaling induced by genotoxic stress. J. Mol. Med. 85, 1187-1202
32. Sun, L., Yao, Y., Liu, B., Lin, Z., Lin, L., Yang, M., Zhang, W., Chen, W., Pan, C., Liu, Q., Song, E., and Li, J. (2012) miR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 31, 432-445
33. Kang, J. H., Song, K. H., Jeong, K. C., Kim, S., Choi, C., Lee, C. H., and Oh, S. H. (2011) Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells. BMC Cancer 11, 334
34. Bollrath, J., and Greten, F. R. (2009) IKK/NF-κB and STAT3 pathways. Central signaling hubs in inflammation-mediated tumor promotion and metastasis. EMBO Rep. 10, 1314-1319
35. Studebaker, A. W., Storci, G., Werbeck, J. L., Sansone, P., Sasser, A. K., Tavolari, S., Huang, T., Chan, M. W., Marini, F. C., Rosol, T. J., Bonafé, M., and Hall, B. M. (2008) Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 68, 9087-9095
36. Sethi, N., and Kang, Y. (2011) Unraveling the complexity of metastasis. Molecular understanding and targeted therapies. Nat. Rev. Cancer 11, 735-748
37. Ribas, J., and Lupold, S. E. (2010) The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer. Cell Cycle 9, 923-929
38. Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., Cvijic, H., Ullmann, A. K., Stadler, P. F., and Horn, F. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110, 1330-1333
39. Ozsolak, F., Poling, L. L., Wang, Z., Liu, H., Liu, X. S., Roeder, R. G., Zhang, X., Song, J. S., and Fisher, D. E. (2008) Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172-3183
40. Vermeulen, L., Vanden Berghe, W., Beck, I. M., De Bosscher, K., and Haegeman, G. (2009) The versatile role of MSKs in transcriptional regulation. Trends Biochem. Sci. 34, 311-318
41. Yang, Y., Xia, F., Hermance, N., Mabb, A., Simonson, S., Morrissey, S., Gandhi, P., Munson, M., Miyamoto, S., and Kelliher, M. A. (2011) A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-κB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol. Cell. Biol. 31, 2774-2786
42. Zhang, S., and Yu, D. (2010) PI(3)King apart PTEN's role in cancer. Clin. Cancer Res. 16, 4325-4330
43. Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., and Lund, A. H. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033
44. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., and Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally down-regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation, and metastasis in colorectal cancer. Oncogene 27, 2128-2136
45. Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., Takatsu, Y., Melamed, J., d'Adda di Fagagna, F., Bernard, D., Hernando, E., and Gil, J. (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018
46. Freund, A., Patil, C. K., and Campisi, J. (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 30, 1536-1548
47. Iliopoulos, D., Hirsch, H. A., and Struhl, K. (2009) An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706
48. Denardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., Rugo, H. S., Hwang, E. S., Jirström, K., West, B. L., and Coussens, L. M. (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1, 54-67
49. Carey, L., Winer, E., Viale, G., Cameron, D., and Gianni, L. (2010) Triple-negative breast cancer. Disease entity or title of convenience? Nat. Rev. Clin. Oncol. 7, 683-692
50. Ohno, M., Natsume, A., Kondo, Y., Iwamizu, H., Motomura, K., Toda, H., Ito, M., Kato, T., and Wakabayashi, T. (2009) The modulation of micro- RNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Mol. Cancer Res. 7, 2022-2030
51. Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., and Struhl, K. (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 39, 493-506
52. Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K., and Iba, H. (2008) miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378, 492-504
53. Ribas, J., Ni, X., Haffner, M., Wentzel, E. A., Salmasi, A. H., Chowdhury, W. H., Kudrolli, T. A., Yegnasubramanian, S., Luo, J., Rodriguez, R., Mendell, J. T., and Lupold, S. E. (2009) miR-21. An androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res. 69, 7165-7169
54. Tjeertes, J. V., Miller, K. M., and Jackson, S. P. (2009) Screen for DNA-damage- responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J. 28, 1878-1889
55. Das, C., Lucia, M. S., Hansen, K. C., and Tyler, J. K. (2009) CBP/p300- mediated acetylation of histone H3 on lysine 56. Nature 459, 113-117
56. Baek, S. H. (2011) When signaling kinases meet histones and histone modifiers in the nucleus. Mol. Cell 42, 274-284
57. Anest, V., Hanson, J. L., Cogswell, P. C., Steinbrecher, K. A., Strahl, B. D., and Baldwin, A. S. (2003) A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423, 659-663
58. Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T., and Gaynor, R. B. (2003) Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655-659
59. Zhong, S., Zhang, Y., Jansen, C., Goto, H., Inagaki, M., and Dong, Z. (2001) MAP kinases mediate UVB-induced phosphorylation of histone H3 at serine 28. J. Biol. Chem. 276, 12932-12937